Header cover image

New Zealand (NZX) Biotech Industry Analysis

UpdatedJan 28, 2023
DataAggregated Company Financials
Companies1
  • 7D-3.1%
  • 3M10.5%
  • 1Y-58.0%
  • YTD-4.0%

Over the last 7 days, the Biotech industry has dropped 2.0%, driven by declines from every company within the industry. However, the industry is down 58% over the past year. Earnings are forecast to grow by 13% annually.

Industry Valuation and Performance

Has the New Zealand Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 28 Jan 2023NZ$397.1mNZ$16.5m-NZ$21,374,000.00n/a-18.6x24.1x
Mon, 26 Dec 2022NZ$405.2mNZ$16.5m-NZ$21,374,000.00n/a-19x24.6x
Wed, 23 Nov 2022NZ$392.9mNZ$13.1m-NZ$19,788,000.00n/a-19.9x29.9x
Fri, 21 Oct 2022NZ$360.5mNZ$13.1m-NZ$19,788,000.00n/a-18.2x27.4x
Sun, 18 Sep 2022NZ$413.2mNZ$13.1m-NZ$19,788,000.00n/a-20.9x31.5x
Tue, 16 Aug 2022NZ$413.2mNZ$13.1m-NZ$19,788,000.00n/a-20.9x31.5x
Thu, 14 Jul 2022NZ$575.2mNZ$13.1m-NZ$19,788,000.00n/a-29.1x43.8x
Sat, 11 Jun 2022NZ$583.3mNZ$13.1m-NZ$19,788,000.00n/a-29.5x44.4x
Mon, 09 May 2022NZ$713.0mNZ$11.5m-NZ$16,115,000.00n/a-44.2x61.9x
Wed, 06 Apr 2022NZ$802.0mNZ$11.5m-NZ$16,115,000.00n/a-49.8x69.6x
Fri, 04 Mar 2022NZ$769.5mNZ$11.5m-NZ$16,115,000.00n/a-47.8x66.8x
Sun, 30 Jan 2022NZ$947.7mNZ$11.5m-NZ$16,115,000.00n/a-58.8x82.3x
Tue, 28 Dec 2021NZ$1.1bNZ$11.5m-NZ$16,115,000.00n/a-65.8x92.1x
Thu, 25 Nov 2021NZ$1.1bNZ$9.0m-NZ$14,223,000.00n/a-79.7x126.3x
Sat, 23 Oct 2021NZ$1.2bNZ$9.0m-NZ$14,223,000.00n/a-83.6x132.5x
Mon, 20 Sep 2021NZ$1.1bNZ$9.0m-NZ$14,223,000.00n/a-76.4x121.1x
Wed, 18 Aug 2021NZ$903.9mNZ$9.0m-NZ$14,223,000.00n/a-63.6x100.7x
Wed, 02 Jun 2021NZ$866.1mNZ$9.0m-NZ$14,223,000.00n/a-60.9x96.5x
Sat, 06 Mar 2021NZ$756.6mNZ$7.6m-NZ$15,406,500.00n/a-49.1x99.3x
Tue, 08 Dec 2020NZ$515.0mNZ$6.3m-NZ$16,590,000.00n/a-31x82.1x
Mon, 31 Aug 2020NZ$470.7mNZ$5.6m-NZ$17,738,000.00n/a-26.5x83.9x
Thu, 04 Jun 2020NZ$82.8mNZ$4.9m-NZ$18,886,000.00n/a-4.4x16.8x
Sun, 08 Mar 2020NZ$85.5mNZ$4.9m-NZ$18,737,000.00n/a-4.6x17.4x
Price to Earnings Ratio

-4.3x


Total Market Cap: NZ$81.4mTotal Earnings: -NZ$18,737,000.00Total Revenue: NZ$4.9mTotal Market Cap vs Earnings and Revenue0%0%0%
New Zealand Biotech Industry Price to Earnings3Y Average -37.9x202120222023
Current Industry PE
    There is only one company in the New Zealander Biotechnology industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 50% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does New Zealand Biotech compare with similar industries?

NZ Market0.45%
Healthcare0.31%
Biotech-3.06%
Biotech-3.06%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

PEB

NZ$0.47

Pacific Edge

7D

-3.1%

1Y

-58.0%